Skip to content
Delayed ~15 min

SOLV Solventum

Health Care · S&P 500

Next earnings: not announced yet

What 18 analyst firms say about Solventum: their latest ratings, price targets and how far the stock is from them. How it works

90.38 USD+3.20 (+3.67%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+0.8%to the avg target 91.07 USD+0.69 USD
Buy 9 · Hold 5 · Sell 2

16 rated views · 19 analyst/firm records · 18 firms

Latest report28 Oct 2026avg report date 12 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8021
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8027

Recent analyst activity · last 90 days

Our tracked history has 7 reports on SOLV from 6 analyst firms in the last 90 days (18 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.

Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.

Latest observed target change: Argus raised its target from $90.00 (set 13 Dec 2025) to $105.00 on 23 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid A ToungBuy23 Oct 2026105.00 USD
BenchmarkUnnamed analystBuy8 Oct 2026—
BMO Capital MarketsVikramjeet S ChopraHold8 Jul 2026Conflicting reports · excluded
BTIGRyan ZimmermanBuy12 Oct 202695.00 USD
CIBC Capital MarketsMark JarviConflictConflicting reports · excluded28 Oct 202635.00 USD
Goldman SachsDavid H RomanSell8 Apr 202667.00 USD
JefferiesMichael ToomeyHold6 Aug 202695.00 USD
KeyBanc Capital MarketsBrett FishbinBuy6 Aug 2026102.00 USD
MizuhoSteven ValiquetteConflictConflicting reports · excluded6 Aug 2026113.00 USD
Piper SandlerJason BednarBuy6 Aug 2026105.00 USD
RedburnJackson PhilipsSell7 Aug 202675.00 USD
StifelRick WiseBuy6 Aug 2026100.00 USD
UBSKevin CaliendoBuy6 Aug 2026101.00 USD
UBSPatrick WoodBuy28 Jul 2026Conflicting reports · excluded
WedbushMichael PiccoloBuy6 Aug 2026101.00 USD
Weiss RatingsUnnamed analyst—18 Aug 2026—
Wells FargoLawrence H BiegelsenHold5 Aug 202689.00 USD
Wolfe ResearchChris SenyekHold2 Mar 2026—
Data feed RESEARCHResearch TeamHold15 Jul 202692.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 04:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.